Organization name

F Care Systems

SRN

BE-MF-000000037

Manufacturer status

Active

5 warnings recorded — scroll inside the panel to see all entries.

• Do not re-use
• Do not resterilize
• Consult instructions for use
• Do not use if package is damaged
• Do not use past indicated date

Primary placement in Belgium; available across 25 countries total.

Trade name

Rafaeloprobe

UDI-DI code

Primary DI

The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.

05425025630608

Basic UDI-DI

Basic UDI-DI

The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.

542502563-ASH001-S2

Reference / catalog number

Rafaelo probe

Issuing entity

UDI issuing entities

Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.

GS1

Risk category

MDR risk classes

MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.

Class IIb

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

Invasive probe for treatment of symptomatic internal haemorrhoids grade II, III and IV.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

1 packaging level registered — each level carries its own UDI-DI.

• 05425025630608× 1 unitBase unit
  • 05425025639601× 10 units

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• G020499GASTROINTESTINAL HAEMOSTASIS DEVICES - OTHER

• Class IIb medical devices in EUDAMED

No certificate specifically references this device's Basic UDI-DI.

Certificate health across this manufacturer's portfolio.